Association between clinical use of lansoprazole and the risk of type 2 diabetes mellitus: a pharmacoepidemiological cohort study

Proton pump inhibitors (PPIs) are common and widely used for gastrointestinal-related disorders. Lansoprazole is one of PPIs with potential benefits of anti-inflammation, reduced oxidative stress, and anti-dia...

Source: Diabetology and Metabolic Syndrome - May 10, 2023 Category: Endocrinology Authors: Ming-Hsun Lin, Wen ‐Tung Wu, Yong-Chen Chen, Tsung-Kun Lin, Yu‐Ching Chou and Chien‐An Sun Tags: Research Source Type: research